Stoddart, L, Smith, NJ & Milligan, G (2008) International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2 and -3: pharmacology and pathophysiological functions. Pharmacol Rev
Luo, J, Swaminath, G, Brown, SP, et al. (2012) A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents. PLoS One
Sykaras, AG, Demenis, C, Case, RM, et al. (2012) Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. PLoS One
Liou, AP, Lu, X, Sei, Y, et al. (2011) The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology
Parker, HE, Habib, AM, Rogers, GJ, et al. (2009) Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia
Leifke, E, Naik, H, Wu, J, et al. (2012) A multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel GPR40 agonist, TAK-875, in subjects with type 2 diabetes. Clin Pharmacol Ther
Burant, CF, Viswanathan, P, Marcinak, J, et al. (2012) TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet
Yashiro, H, Tsujihata, Y, Takeuchi, K, et al. (2012) The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets. J Pharmacol Exp Ther
Bailey, CJ (2012) Could FFAR1 assist insulin secretion in type 2 diabetes?
Koch, L (2012) Diabetes: FFAR1 activation improves glycemia. Nat Rev Endocrinol
Sum, CS, Tikhonova, IG, Neumann, S, et al. (2007) Identification of residues important for agonist recognition and activation in GPR40. J Biol Chem
282, 29 248–29 255.
Smith, NJ, Stoddart, LA, Devine, NM, et al. (2009) The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1. J Biol Chem
284, 17 527–17 539.
Lin, D, Guo, Q, Luo, J, et al. (2012) Identification and pharmacological characterization of multiple allosteric binding sites on the FFA1 receptor. Mol Pharmacol
Shanahan, F (2011) The colonic microflora and probiotic therapy in health and disease. Curr Opin Gastroenterol
Burcelin, R, Luche, E, Serino, M, et al. (2009) The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?
Esteve, E, Ricart, W & Fernández-Real, JM (2011) Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Curr Opin Clin Nutr Metab Care
Sina, C, Gavrilova, O, Förster, M, et al. (2009) G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol
Maslowski, KM, Vieira, AT, Ng, A, et al. (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature
Hoveyda, H, Brantis, CE, Dutheuil, G, et al. (2010) Compounds, pharmaceutical composition and methods for use in treating metabolic disorders. International patent application WO 2010/066682 A1.
Saniere, L, Raymond, M, Pizzonero, MR, et al. (2102) Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases. International patent application WO 2012/098033 A1.
Vinolo, MA, Ferguson, GJ, Kulkarni, S, et al. (2011) SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One
Tolhurst, G, Heffron, H, Lam, YS, et al. (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes
Zaibi, MS, Stocker, CJ, O'Dowd, J, et al. (2010) Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett
Schmidt, J, Smith, NJ, Christiansen, E, et al. (2011) Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J Biol Chem
Ge, H, Li, X, Weiszmann, J, et al. (2008) Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology
Hudson, BD, Tikhonova, IG, Pandey, SK, et al. (2012) Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3. J Biol Chem
Hudson, BD, Christiansen, E, Tikhonova, IG, et al. (2012) Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J
Wang, A, Akers, RM & Jiang, H (2012) Presence of G protein-coupled receptor 43 in rumen epithelium but not in the islets of Langerhans in cattle. J Dairy Sci
Wang, J, Wu, X, Simonavicius, N, et al. (2006) Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J Biol Chem
Nagasaki, H, Kondo, T, Fuchigami, M, et al. (2012) Inflammatory changes in adipose tissue enhance expression of GPR84, a medium-chain fatty acid receptor: TNFα enhances GPR84 expression in adipocytes. FEBS Lett
Oh, DY, Talukdar, S, Bae, EJ, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell
Saltiel, AR (2010) Fishing out a sensor for anti-inflammatory oils. Cell
Calder, PC (2013) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Br J Clin Pharmacol
Hirasawa, A, Tsumaya, K, Awaji, T, et al. (2005) Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med
Ma, J, Novack, A, Nashashibi, I, et al. (2010) Aryl GPR120 receptor agonists and uses thereof. United States Patent Application 20100216827.
Dong, F-S, Jiangao, S & Ma, J, et al. (2012)
Shimpukade, B, Hudson, BD, Hovgaard, CK, et al. (2012) Discovery of a potent and selective GPR120 agonist. J Med Chem
Taneera, J, Lang, S, Sharma, A, et al. (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab
Ichimura, A, Hirasawa, A, Poulain-Godefroy, O, et al. (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature
Moore, K, Zhang, Q, Murgolo, N, et al. (2009) Cloning, expression, and pharmacological characterization of the GPR120 free fatty acid receptor from cynomolgus monkey: comparison with human GPR120 splice variants. Comp Biochem Physiol B Biochem Mol Biol
Watson, SJ, Brown, AJ & Holliday, ND (2012) Differential signaling by splice variants of the human free fatty acid receptor GPR120. Mol Pharmacol